Source: Journal of Oncology Pharmacy Practice. Unidades: EERP, FCFRP, FMRP
Subjects: DOENÇA ENXERTO-HOSPEDEIRO, TRANSPLANTE DE ÓRGÃOS, CÉLULAS-TRONCO, HOSPITALIZAÇÃO, SERVIÇOS FARMACÊUTICOS, FARMACOTERAPIA, ESTUDOS RETROSPECTIVOS
ABNT
ZANETTI, Maria Olívia Barboza et al. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team. Journal of Oncology Pharmacy Practice, v. 29, n. 2, p. 375-385, 2023Tradução . . Disponível em: https://doi.org/10.1177/10781552211073797. Acesso em: 18 nov. 2024.APA
Zanetti, M. O. B., Rodrigues, J. P. V., Varallo, F. R., Cunha, R. L. G., Simões, B. P., & Pereira, L. R. L. (2023). Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team. Journal of Oncology Pharmacy Practice, 29( 2), 375-385. doi:10.1177/10781552211073797NLM
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 375-385.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1177/10781552211073797Vancouver
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 375-385.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1177/10781552211073797